| Literature DB >> 15027063 |
Abstract
Botulinum toxin is now the first-line therapy for writer's cramp and other occupational dystonias, with well-established efficacy and safety. Future studies will allow us to understand better the physiological effects of injection and to refine and enhance our treatment of focal hand dystonia. Copyright 2004 Movement Disorder SocietyEntities:
Mesh:
Substances:
Year: 2004 PMID: 15027063 DOI: 10.1002/mds.20025
Source DB: PubMed Journal: Mov Disord ISSN: 0885-3185 Impact factor: 10.338